Steris PLC (STE)
229.07
+3.08
(+1.36%)
USD |
NYSE |
May 10, 14:49
Steris Enterprise Value: 25.46B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 09, 2024 | 25.46B |
May 08, 2024 | 23.89B |
May 07, 2024 | 24.16B |
May 06, 2024 | 23.83B |
May 03, 2024 | 23.66B |
May 02, 2024 | 23.51B |
May 01, 2024 | 23.39B |
April 30, 2024 | 23.34B |
April 29, 2024 | 23.43B |
April 26, 2024 | 23.27B |
April 25, 2024 | 23.04B |
April 24, 2024 | 23.17B |
April 23, 2024 | 23.48B |
April 22, 2024 | 22.98B |
April 19, 2024 | 22.84B |
April 18, 2024 | 22.97B |
April 17, 2024 | 22.91B |
April 16, 2024 | 22.79B |
April 15, 2024 | 23.01B |
April 12, 2024 | 23.28B |
April 11, 2024 | 23.51B |
April 10, 2024 | 23.80B |
April 09, 2024 | 24.34B |
April 08, 2024 | 24.14B |
April 05, 2024 | 24.22B |
Date | Value |
---|---|
April 04, 2024 | 24.21B |
April 03, 2024 | 24.53B |
April 02, 2024 | 24.50B |
April 01, 2024 | 24.97B |
March 28, 2024 | 25.34B |
March 27, 2024 | 25.41B |
March 26, 2024 | 25.02B |
March 25, 2024 | 24.93B |
March 22, 2024 | 25.76B |
March 21, 2024 | 25.57B |
March 20, 2024 | 26.18B |
March 19, 2024 | 25.87B |
March 18, 2024 | 25.85B |
March 15, 2024 | 25.86B |
March 14, 2024 | 26.01B |
March 13, 2024 | 26.23B |
March 12, 2024 | 26.23B |
March 11, 2024 | 26.23B |
March 08, 2024 | 26.22B |
March 07, 2024 | 26.15B |
March 06, 2024 | 25.76B |
March 05, 2024 | 25.69B |
March 04, 2024 | 26.18B |
March 01, 2024 | 26.13B |
February 29, 2024 | 26.14B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.09B
Minimum
Mar 23 2020
28.06B
Maximum
Apr 20 2022
20.21B
Average
21.43B
Median
Jan 05 2023
Enterprise Value Benchmarks
Edwards Lifesciences Corp | 51.65B |
ResMed Inc | 32.62B |
Stryker Corp | 136.50B |
Align Technology Inc | 20.22B |
Nutriband Inc | 36.57M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 140.74M |
Revenue (Quarterly) | 1.396B |
Total Expenses (Quarterly) | 1.179B |
EPS Diluted (Quarterly) | 1.42 |
Gross Profit Margin (Quarterly) | 43.18% |
Profit Margin (Quarterly) | 10.08% |
Earnings Yield | 2.49% |
Operating Earnings Yield | 3.57% |
Normalized Earnings Yield | 2.494 |